Mankind Pharma Limited logo

Mankind Pharma Limited

TickerMANKIND.NSVenueNSESectorHealthcarePrimary listingBeta0.45

Mankind Pharma Limited is an India-based company in the Healthcare sector with a market capitalisation of $9.8B. Its FinScore is 62/100; its highest-scoring layer is Quality (75) and its lowest is Value (40). The shares trade at 46.0x trailing earnings and are up 5% year to date.

Market cap
$9.8B
P/E (TTM)
46.0x
ROE
12.7%

Share price performance

Loading chart…

About Mankind Pharma Limited

www.mankindpharma.com

Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.

Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
HQ
India
Fiscal year-end
March
Trading currency
INR
Reporting currency
INR
Fundamentals updated
65 days ago
Market
Market cap
$9.8B
Shares outstanding
413.0M
P/E (TTM)
46.0x
Beta (issuer)
0.45
Revenue (latest FY)
₹142.8B

Revenue breakdown

Revenue split not available

FinScore

As of 2026-10-19
Overall62
Quality75
Growth51
Value40
Momentum68
Relative Strength82

Snapshot

Ownership

Free float
27.4%
Shares outstanding
413.0M

Holder data is not available for this company yet.

Sign up or log in to see Analysis

Analysis for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Mankind Pharma Limited is available to Finryse members. The Overview stays open to everyone; creating an account is free.